Results of a prove of concept study (C210) of telaprevir monotherapy and in combination with peginterferon alfa-2a and ribavirin in treatment-naive genotype 4 HCV patients - Benhamou, Y; Moussalli, J; Ratziu, V (J Hepatol, 2009)
et al.